Skip to main content

Address

Panerių g. 246
48454 Kaunas
Lithuania

Opening hours

  • Mon – Fri
    9 :00 – 17 00
  • Sat
    Closed    
  • Sun
    Closed   
PharmaDNA

Cancer genetic tests

Genetic and genomic tests provide different types of information: about inherited predisposition, tumour biology or disease prognosis. The appropriate test is selected according to the specific clinical question.
Consultation with documents. Illustrative photograph.
Genetic and genomic information

Different tests answer different questions

How can genetic information help?

Some tests assess inherited changes, while others examine the characteristics of an already diagnosed tumour. Results may supplement risk assessment or help inform discussions about further treatment decisions. There is no single universal cancer detection test.

Accuracy, data protection and a clear explanation

In its presentation of its tests, Myriad emphasises accurate results, personal data protection and clearly presented information. It is important to interpret the test result with a doctor: it provides additional information but does not in itself guarantee successful treatment.

From a question to the right test

A doctor assesses whether the test is suitable and interprets the result. The purpose, sample requirements and limitations of each test are described on its page. Contact PharmaDNA for practical questions about arranging a test.

Purpose of the tests

Which question can the test answer?

What is Prolaris used for?

Prolaris is a gene expression test of prostate tumour tissue that provides the doctor with additional information about tumour aggressiveness.

About the test

What is MyChoice used for?

MyChoice tests ovarian tumours for homologous recombination deficiency (HRD). This information helps the doctor consider PARP inhibitor treatment options.

About the test

What is MyRisk used for?

MyRisk is a genetic test for hereditary cancer predisposition. Its result is considered alongside personal and family cancer history when planning further healthcare.

About the test

What is BRACAnalysis CDx used for?

BRACAnalysis CDx is a blood test for inherited changes in the BRCA1 and BRCA2 genes. In people with cancer, its result may help the doctor assess PARP inhibitor treatment options.

About the test

What is EndoPredict used for?

EndoPredict helps assess the risk of distant recurrence in early-stage oestrogen receptor-positive (ER+), HER2-negative (HER2−) breast cancer and discuss the benefits of additional treatment.

About the test

Have questions about testing?

Contact us about arranging the test and the documents required.
Ask about the test